Your search returned 11 results.

Results
	1.	Clinical benefit of eribulin (Halaven [electronic resource] by Koyama, Noriyuki Taniguchi, Shigeru Kodama, Kotaro Tohyama, Osamu Hasegawa, Hiroki Semba, Taro Producer: 20170410 In: Nihon yakurigaku zasshi. Folia pharmacologica Japonica vol. 148 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Multitargeting strategy using lenvatinib and golvatinib: maximizing anti-angiogenesis activity in a preclinical cancer model. [electronic resource] by Nakazawa, Youya Kawano, Satoshi Matsui, Junji Funahashi, Yasuhiro Tohyama, Osamu Muto, Hiroki Nakagawa, Takayuki Matsushima, Tomohiro Producer: 20150416 In: Cancer science vol. 106 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Klotho is a novel beta-glucuronidase capable of hydrolyzing steroid beta-glucuronides. [electronic resource] by Tohyama, Osamu Imura, Akihiro Iwano, Akiko Freund, Jean-Noël Henrissat, Bernard Fujimori, Toshihiko Nabeshima, Yo-ichi Producer: 20040519 In: The Journal of biological chemistry vol. 279 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane. [electronic resource] by Imura, Akihiro Iwano, Akiko Tohyama, Osamu Tsuji, Yoshihito Nozaki, Kazuhiko Hashimoto, Nobuo Fujimori, Toshihiko Nabeshima, Yo-Ichi Producer: 20040623 In: FEBS letters vol. 565 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	E7050: a dual c-Met and VEGFR-2 tyrosine kinase inhibitor promotes tumor regression and prolongs survival in mouse xenograft models. [electronic resource] by Nakagawa, Takayuki Tohyama, Osamu Yamaguchi, Atsumi Matsushima, Tomohiro Takahashi, Keiko Funasaka, Setsuo Shirotori, Shuji Asada, Makoto Obaishi, Hiroshi Producer: 20100330 In: Cancer science vol. 101 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Antitumor activity of lenvatinib (e7080): an angiogenesis inhibitor that targets multiple receptor tyrosine kinases in preclinical human thyroid cancer models. [electronic resource] by Tohyama, Osamu Matsui, Junji Kodama, Kotaro Hata-Sugi, Naoko Kimura, Takayuki Okamoto, Kiyoshi Minoshima, Yukinori Iwata, Masao Funahashi, Yasuhiro Producer: 20141008 In: Journal of thyroid research vol. 2014 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Wif1 and Ifitm3 gene expression preferentially altered in the colon mucosa of benzo[a]pyrene pre-treated mice following exposure to dextran sulfate sodium. [electronic resource] by Koyama, Naoki Hakura, Atsushi Toritsuka, Naoki Sonoda, Jiro Seki, Yuki Tohyama, Osamu Asakura, Shoji Nakano-Ito, Kyoko Hosokawa, Satoru Producer: 20160315 In: Chemico-biological interactions vol. 240 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Targeting of tumor growth and angiogenesis underlies the enhanced antitumor activity of lenvatinib in combination with everolimus. [electronic resource] by Matsuki, Masahiro Adachi, Yusuke Ozawa, Yoichi Kimura, Takayuki Hoshi, Taisuke Okamoto, Kiyoshi Tohyama, Osamu Mitsuhashi, Kaoru Yamaguchi, Atsumi Matsui, Junji Funahashi, Yasuhiro Producer: 20170926 In: Cancer science vol. 108 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models. [electronic resource] by Funahashi, Yasuhiro Okamoto, Kiyoshi Adachi, Yusuke Semba, Taro Uesugi, Mai Ozawa, Yoichi Tohyama, Osamu Uehara, Taisuke Kimura, Takayuki Watanabe, Hideki Asano, Makoto Kawano, Satoshi Tizon, Xavier McCracken, Paul J Matsui, Junji Aoshima, Ken Nomoto, Kenichi Oda, Yoshiya Producer: 20141217 In: Cancer science vol. 105 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Microregional antitumor activity of a small-molecule hypoxia-inducible factor 1 inhibitor. [electronic resource] by Okamoto, Kiyoshi Ito, Daisuke Miyazaki, Kazuki Watanabe, Saori Tohyama, Osamu Yokoi, Akira Ozawa, Yoichi Asano, Makoto Kawamura, Takanori Yamane, Yoshinobu Nagao, Satoshi Funasaka, Setsuo Kamata, Junichi Kotake, Yoshihiko Aoki, Mika Tsukahara, Naoko Mizui, Yoshiharu Tanaka, Isao Sawada, Kohei Producer: 20120529 In: International journal of molecular medicine vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage. [electronic resource] by Yamamoto, Yuji Matsui, Junji Matsushima, Tomohiro Obaishi, Hiroshi Miyazaki, Kazuki Nakamura, Katsuji Tohyama, Osamu Semba, Taro Yamaguchi, Atsumi Hoshi, Sachi Suzuki Mimura, Fusayo Haneda, Toru Fukuda, Yoshio Kamata, Jun-Ichi Takahashi, Keiko Matsukura, Masayuki Wakabayashi, Toshiaki Asada, Makoto Nomoto, Ken-Ichi Watanabe, Tatsuo Dezso, Zoltan Yoshimatsu, Kentaro Funahashi, Yasuhiro Tsuruoka, Akihiko Producer: 20140908 In: Vascular cell vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)